This document provides an overview of platelet function and dysfunction. It discusses platelet production, structure, activation pathways, assessment of function, and inherited and acquired disorders. Key points include: platelets are produced from megakaryocytes at a rate of 1 trillion per day; contain granules storing factors like ADP and serotonin; activate via receptors for collagen, thrombin, ADP; aggregation is mediated by integrin GP IIb/IIIa; testing includes aggregometry and PFA-100; inherited disorders impact receptors like Glanzmann thrombasthenia or Bernard-Soulier syndrome; and acquired causes include medications like aspirin or clopidogrel that inhibit platelet activation pathways.
Here's important & condensed ppt slides about hemostasis and its orchestrated steps and cogulation cascade, roles of endothelium,platelets and Coagulation protiens....!
Here's important & condensed ppt slides about hemostasis and its orchestrated steps and cogulation cascade, roles of endothelium,platelets and Coagulation protiens....!
Fetal hemoglobin and rh incompatibilityrohini sane
A comprehensive presentation on fetal hemoglobin & Rh incompatibility for undergraduate medical, dental, biotechnology & pharmacology students for self-learning .Presentation has physical & chemical properties of fetal hemoglobin along with its function. Binding affinity for O₂ of HbF and oxygen dissociation curve for HbF elucidated with suitable diagrams. Molecular constitution of Embryonic Hb ( Grover I &Grover II )with electrophoretic patterns are presented here . Importance of Kleihauer staining for detection of fetal cells is described briefly.
Diagrammatic representation of Rh- incompatibility is done for complete understanding of the concept. Signs & symptoms Kernicterus are presented diagrammatically.
Direct and indirect Coomb’s Test for Rh- incompatibility for diagnosis of Erythroblastosis Fetalis is illustrated. Biochemical aspects of Hemolytic Disease of Newborn (HDN) and Physiological /Neonatal Jaundice are presented. Comparison of Causes & biochemical findings for Hemolytic Jaundice along hepatic and obstructive jaundice is done in this presentation.
Molecular mechanism involved in biosynthesis of Hb Bart and Hb H along with their electrophoretic patterns for their detection are illustrated.
Hereditary persistent fetal Hb( HPFH ) & Point mutations causing HPFH are described in lucid manner. Google images are used for intense impact of the subject.
In Fibrinolytic system the clots are broken down regularly to maintain the blood flow. I case of certain disease this system is altered and produce coagulation abnormalities and diseases like MI , stroke etc.
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
Fetal hemoglobin and rh incompatibilityrohini sane
A comprehensive presentation on fetal hemoglobin & Rh incompatibility for undergraduate medical, dental, biotechnology & pharmacology students for self-learning .Presentation has physical & chemical properties of fetal hemoglobin along with its function. Binding affinity for O₂ of HbF and oxygen dissociation curve for HbF elucidated with suitable diagrams. Molecular constitution of Embryonic Hb ( Grover I &Grover II )with electrophoretic patterns are presented here . Importance of Kleihauer staining for detection of fetal cells is described briefly.
Diagrammatic representation of Rh- incompatibility is done for complete understanding of the concept. Signs & symptoms Kernicterus are presented diagrammatically.
Direct and indirect Coomb’s Test for Rh- incompatibility for diagnosis of Erythroblastosis Fetalis is illustrated. Biochemical aspects of Hemolytic Disease of Newborn (HDN) and Physiological /Neonatal Jaundice are presented. Comparison of Causes & biochemical findings for Hemolytic Jaundice along hepatic and obstructive jaundice is done in this presentation.
Molecular mechanism involved in biosynthesis of Hb Bart and Hb H along with their electrophoretic patterns for their detection are illustrated.
Hereditary persistent fetal Hb( HPFH ) & Point mutations causing HPFH are described in lucid manner. Google images are used for intense impact of the subject.
In Fibrinolytic system the clots are broken down regularly to maintain the blood flow. I case of certain disease this system is altered and produce coagulation abnormalities and diseases like MI , stroke etc.
This presentation is focused on diagnostic utility of Red blood cell indices which will be very useful for undergraduate and postgraduate of medical field.
A presentation about DIC (Disseminated Intravascular Coagulopathy).
Done by 4th year medical students at the University of Science and Technology, Sana'a, Republic of Yemen, in October 2010.
Primary and Secondary Hemostasis is Discussed
This is a copy of a lecture provided as an overview of platelet disorders for board preparation to the MercyOne Des Moines Internal Medicine Residency
Disseminated Intravascular coagulation is a very common and life endangering pathological condition due to consumptive coagulopathy.
This is a very serious disease and prompt diagnosis may help in early initiation of treatment.
Coagulation: In medicine, the clotting of blood. The process by which the blood clots to form solid masses, or clots.
More than 30 types of cells and substances in blood affect clotting. The process is initiated by blood platelets. Platelets produce a substance that combines with calcium ions in the blood to form thromboplastin, which in turn converts the protein prothrombin into thrombin in a complex series of reactions. Thrombin, a proteolytic enzyme, converts fibrinogen, a protein substance, into fibrin, an insoluble protein that forms an intricate network of minute threadlike structures called fibrils and causes the blood plasma to gel. The blood cells and plasma are enmeshed in the network of fibrils to form the clot.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
Sudheer Mechineni, Head of Application Frameworks, Standard Chartered Bank
Discover how Standard Chartered Bank harnessed the power of Neo4j to transform complex data access challenges into a dynamic, scalable graph database solution. This keynote will cover their journey from initial adoption to deploying a fully automated, enterprise-grade causal cluster, highlighting key strategies for modelling organisational changes and ensuring robust disaster recovery. Learn how these innovations have not only enhanced Standard Chartered Bank’s data infrastructure but also positioned them as pioneers in the banking sector’s adoption of graph technology.
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Albert Hoitingh
In this session I delve into the encryption technology used in Microsoft 365 and Microsoft Purview. Including the concepts of Customer Key and Double Key Encryption.
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfPaige Cruz
Monitoring and observability aren’t traditionally found in software curriculums and many of us cobble this knowledge together from whatever vendor or ecosystem we were first introduced to and whatever is a part of your current company’s observability stack.
While the dev and ops silo continues to crumble….many organizations still relegate monitoring & observability as the purview of ops, infra and SRE teams. This is a mistake - achieving a highly observable system requires collaboration up and down the stack.
I, a former op, would like to extend an invitation to all application developers to join the observability party will share these foundational concepts to build on:
A tale of scale & speed: How the US Navy is enabling software delivery from l...sonjaschweigert1
Rapid and secure feature delivery is a goal across every application team and every branch of the DoD. The Navy’s DevSecOps platform, Party Barge, has achieved:
- Reduction in onboarding time from 5 weeks to 1 day
- Improved developer experience and productivity through actionable findings and reduction of false positives
- Maintenance of superior security standards and inherent policy enforcement with Authorization to Operate (ATO)
Development teams can ship efficiently and ensure applications are cyber ready for Navy Authorizing Officials (AOs). In this webinar, Sigma Defense and Anchore will give attendees a look behind the scenes and demo secure pipeline automation and security artifacts that speed up application ATO and time to production.
We will cover:
- How to remove silos in DevSecOps
- How to build efficient development pipeline roles and component templates
- How to deliver security artifacts that matter for ATO’s (SBOMs, vulnerability reports, and policy evidence)
- How to streamline operations with automated policy checks on container images
Elevating Tactical DDD Patterns Through Object CalisthenicsDorra BARTAGUIZ
After immersing yourself in the blue book and its red counterpart, attending DDD-focused conferences, and applying tactical patterns, you're left with a crucial question: How do I ensure my design is effective? Tactical patterns within Domain-Driven Design (DDD) serve as guiding principles for creating clear and manageable domain models. However, achieving success with these patterns requires additional guidance. Interestingly, we've observed that a set of constraints initially designed for training purposes remarkably aligns with effective pattern implementation, offering a more ‘mechanical’ approach. Let's explore together how Object Calisthenics can elevate the design of your tactical DDD patterns, offering concrete help for those venturing into DDD for the first time!
Communications Mining Series - Zero to Hero - Session 1DianaGray10
This session provides introduction to UiPath Communication Mining, importance and platform overview. You will acquire a good understand of the phases in Communication Mining as we go over the platform with you. Topics covered:
• Communication Mining Overview
• Why is it important?
• How can it help today’s business and the benefits
• Phases in Communication Mining
• Demo on Platform overview
• Q/A
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
GraphRAG is All You need? LLM & Knowledge GraphGuy Korland
Guy Korland, CEO and Co-founder of FalkorDB, will review two articles on the integration of language models with knowledge graphs.
1. Unifying Large Language Models and Knowledge Graphs: A Roadmap.
https://arxiv.org/abs/2306.08302
2. Microsoft Research's GraphRAG paper and a review paper on various uses of knowledge graphs:
https://www.microsoft.com/en-us/research/blog/graphrag-unlocking-llm-discovery-on-narrative-private-data/
PHP Frameworks: I want to break free (IPC Berlin 2024)Ralf Eggert
In this presentation, we examine the challenges and limitations of relying too heavily on PHP frameworks in web development. We discuss the history of PHP and its frameworks to understand how this dependence has evolved. The focus will be on providing concrete tips and strategies to reduce reliance on these frameworks, based on real-world examples and practical considerations. The goal is to equip developers with the skills and knowledge to create more flexible and future-proof web applications. We'll explore the importance of maintaining autonomy in a rapidly changing tech landscape and how to make informed decisions in PHP development.
This talk is aimed at encouraging a more independent approach to using PHP frameworks, moving towards a more flexible and future-proof approach to PHP development.
5. Thrombopoiesis
• Humans produce 1x 10^11 platelets per day
• Can increase 10-20 fold
• Each megakaryocyte can produce 1000
platelets
• The lifespan of a platelet is approximately 10
days
• Platelet production from MK progenitors takes
4-7days
• Most of this time is for the maturation of the
megakaryocyte
• Endomitosis
• Cytoplasmic maturation
6. Thrombopoietin
• TPO is one of the key factors for platelet production
• Produced constitutively by the liver (and kidney)
• Circulating levels are determined by the megakaryocyte and
platelet biomass
• Low platelets more circulating TPO increased platelet
production
• ITP is an exception to this
• Normal platelets-> low TPO->low platelet production
12. Adhesion Phase: vWF
GP Ib/IX/V Complex
• Major receptor modulating interaction with vWF
• GP Ibα is essential for arterial thrombus formation (Fab
development)
• No inherent signaling ability (no coupling to G proteins,
no TK activity)
• Found in lipid rafts in association with other GPs
• Defects define Bernard Soulier Syndrome
• Macrothrombocytopenia
• No response to ristocetin on aggregometry
13. AdhesionPhase: Collagen
GP VI
• Low-affinity but high impact for binding to collagen
• Signals through Src kinases, as well as association with
FcRg dimer which signals through ITAMs
• Ab in development blocks thrombosis but does not
prolong bleeding time
GP Ia/IIa
No specific human disease has been identified with a
defect in either
14.
15. Platelet Activation:
Granule Secretion and Integrin Activation
• Initial binding leads to the release of agonists from the first-responding
platelets which in turn leads to recruitment and activation of other near-by
platelets
• ADP
• TxA2
• Epinephrine
• Thrombin
• All lead to the activation of GP IIb/IIIa (αIIb/β3 integrin) via inside-out signaling
• Also lead to more granule secretion->feed forward mechanism
• Activation of GPIIb/IIIa allows it to bind to fibrinogen (and vWF), to cross link
platelets and allow the thrombus to form
17. Granule Secretion/GPCRs:
ADP and P2Y1 and P2Y12 Receptors
• Released from platelet dense granules and from RBCs
• Interacts with the GPCRs
• Leads to Ca elevation, TxA2 synthesis, protein
phosphorylation, and shape change, granule secretion,
activation of GPIIb/IIIa and aggregation
• P2Y12 is more important
• Few patients identified with dysfunction and bleeding
diathesis
• Major target of thienopyridine drugs
• P2Y1 is necessary for full signaling and is a potential drug target
18. GPCRs:
Thromboxane A2 and Tpa receptor
• The product of COX and TxA2 synthase enzymes using
arachadonic acid (AA) as a precursor
• Freely diffuses across plasma membrane
• High activity during aggregation when platelets are
closely apposed
• Causes shape change, phospholipid hydrolysis, Ca
mobilization, secretion, and aggregation via the TPa
receptor
• Aspirin inhibits COX-1 irreversibly
19. GPCRs:
Epinephrine and α2A Receptor
• Weak agonist—cannot induce shape change or activate PLC
• Reduces levels of cAMP within the platelet
20. GPCRs:
Thrombin and PAR receptors
• Likely the most potent platelet activator
• Acts via PAR-1 and PAR-4 (protease activated receptors)
• The ligand is tethered to the receptor but hidden until it is
cleaved
Nature 407, 258-264(14 September 2000)
• Also Ib/IX/V complex
• Impaired thrombin responsiveness in BSS—Ib/IX possibly localizes
thrombin to the PARs
• PAR-1 is likely the primary mediator, but PAR4 is necessary for full
activation
• No clinical examples of PAR deficiencies have been described
23. Evaluation of Platelet Function
•
•
•
•
•
Peripheral Blood Smear
Bleeding Time
PFA-100
Platelet aggregometry and secretion
Thromboelastography
24. Peripheral Blood Smear
• Keys to look for:
– Number of platelets
– Size of platelets
– Granulations within platelets
– WBC inclusions
25. Bleeding Time
• Controversial, and mainly abandoned
• Invasive, difficult to standardize
• Requires dedicated technician to perform test
over a relatively long period of time on one
patient
26. PFA-100
Epi or ADP
collagen
collagen
• Rapid, automated, general
assessment of platelet and overall
hemostatic function
– Replacing bleeding time
• Citrated whole blood passed
through aperture and time to
closure with platelet plug is
measured
– Collagen with either epinephrine
or ADP
• High negative predictive value;
low specificity
27. PFA-100
• Influenced by many factors:
– Hematocrit
– Platelet count
– Blood group
– Timing and processing
28.
29. Platelet Aggregometry
• Usually performed on platelet-rich plasma
• Measures transmission of light through the
solution full of platelets
– As platelets aggregate, light transmission
increases
• Uses a panel of agonists to determine specific
defect
• Not well-standardized
30.
31. Aggregometry
• Weak agonists:
– ADP and epinephrine: biphasic platelet aggregation
• Strong agonists
– Collagen, TRAP (thrombin), arachadonic acid TXA2
• (Ristocetin: Agglutination)
• Can also measure secretion of ATP and ADP
34. Bernard-Soulier Syndrome
•
•
•
•
•
•
Reduced/lack of GP Ib/IX
Rare, autosomal recessive
Moderate thrombocytopenia
Large platelets
Prolonged bleeding time
Lack of response to ristocetin on platelet
aggregometry (agglutination)
– All other agonists are normal
• ITP vs BSS
• Can diagnose via flow cytometry
35. Glanzmann Thombasthenia
• Qualitative and/or quantitative abnormality of GP
IIb/IIIa
• More severe mucocutaneous bleeding than other
platelet disorders
• Rare, autosomal recessive
• No aggregation response to any agonists except
ristocetin
• Normal secretion to thrombin, but reduced to
weak agonists
• Can diagnose via flow cytometry
36. Storage Pool Disorders:
Dense Granules
• 3-8 dense granules per platelet; will not see
problems on light microscopy
• Contain ADP, ATP, serotonin, Ca, pyrophosphate
• Moderate bleeding diathesis
• Second wave of aggregation to ADP and Epi is lost
• Reduced collagen response
• Seen in association with Hermansky-Pudlak, ChediakHigashi, and Wiskott Aldrich, TAR, and Griscelli
syndromes
37. Hermansky-Pudlak
• Rare autosomal disorder
• Largest concentration in
Puerto Rico
• Occulocutaneous albinism,
congenital nystagmus,
decreased visual acuity
• Also granulomatous colitis
and pulmonary fibrosis
39. Storage Pools Disorders:
Alpha Granules
•
Gray platelet syndrome
–
–
–
–
–
Mild thrombocytopenia
Macrothrombocytopenia
Pale platelets on light microscopy
Variable inheritance
Variable aggregation patterns
•
•
Response to ADP and epi normal
Collage, thrombin, and ADP impaired
– Splenomegaly, fibrosis
•
Quebec platelet disorder
– Autosomal dominant
– Delayed bleeding
– Increased proteolysis of alpha granule proteins (elevated platelet urokinase type plasminogen
activator)
– Thrombocytopenia
– Reduced aggregation with epinephrine
40. Signal Transduction and Activation
Abnormalities
• Abnormalities for specific agonist receptors or
abnormalities of the signal transduction
cascade
– G proteins, phospholipase C, calcium mobilization,
pleckstrin phosphorylation, phospholipase C, PKD
– Thromboxane synthesis
41. MYH-9 abnormalities (May-Hegglin)
• MYH-9 mutations (myosin heavy chain)
• Macrothrombocytopenia
• Most commonly described as MayHegglin;
– Fechtner, Epstein, Sebastian Syndromes
are all part of the same spectrum
• Neutrophil inclusions (Dohle bodies)
• Abnormalities in kidneys, ears, heart
42. Wiskott-Aldrich
• Characterized by moderate to severe
thrombocytopenia, with small platelet volumes
• Wide clinical variability:
– susceptibility to infections associated with adaptive
and innate immune deficiency
– eczema
– isolated thrombocytopenia
– X-linked neutropenia (XLN)
• Mutation is WASP—actin remodeling protein
• Platelet volumes are usually 3.5-5fL (normal=710fL)
43. Scott Syndrome
• Defect in platelet pro-coagulant activity
• Failure to move phosphatidylserine to the
outer membrane
• Normal bleeding time and normal platelet
aggregation
44. Bleeding disorder
Low Platelet Count
Small Platelets
Large Platelets
Normal Platelet Count, Normal Size
Very Abnormal
Aggregometry
Normal
Aggregometry
Glanzmann
Wiskott-Aldrich
No Color Issues
Bernard Soulier
Scott
Quebec
Color Issues
Pale Platelets
Pale People
Gray Platelet
Normal Neutrophils
Kind-of adapted from
Williams Hematology,
7th Ed.
Neutrophil Inclusions
Hermansky-Pudlack
Chediak-Higashi
46. Aspirin
• Irreversibly inhibits COX-1 and leads to
inhibition of thromboxane A2 production
• The most common antithrombotic in use
• Inhibition with low-dose is complete (50100mg)
– Essential thrombocythemia
• Major bleeding risk is approximately 1% per
year
• Other NSAIDs block COX-1 to a lesser degree
47. Thienopyridines
• Clopidogrel, ticlopidine, and prasagurel
• Work (mainly? in part?) by blocking the ADP
receptor
• Multiple methods to asses effect:
aggregometry, PFA-100 (ADP), Verify-Now
– All have significant variability in detection of
‘resistance’ and questionable clinical utility
48. GP IIb/IIIa inhibitors
• Abciximab, eptifibatide, tirofiban
• Complete thrombasthenic state (Glanzman’s
thrombasthenia)
• High incidence of bleeding complications
• May also cause acute thrombocytopenia
–
–
–
–
Rapid onset, 30min to one day
Variable recovery
May be severe
May also induce platelet clumping/
pseudothrombocytopenia
49. Other medications
• Penicillins (especially high dose)
– Onset 2-3d, lasts 3-10d after discontinuation
• Cephalosporins
• SSRIs